Coenzyme Q10 pharmaceutical composition

The present invention discloses a pharmaceutical composition coenzyme Q10, including the following components: (1) coenzyme Q10 as an active ingredient, (2) polyethylene glycol 15 hydroxystearate (Solutol HS 15), polysorbate, polyethylene glycol (PEG), poloxamers (poloxamer), polyoxyethylene castor oil derivative is one or more solubilizing agents, (3) in a medium chain glycerol ester and derivatives a fatty acid or a long chain saturated or unsaturated more oily components, (4) water for injection as a solvent. You may also be added one or more excipients, antioxidants, tonicity adjusting agent, prepared as lyophilized formulations and injections. Injection of the present invention is made of injection of coenzyme Q10 in coenzyme Q10 more traditional injection and transport having better storage stability, safety and patient compliance of higher clinical medication. The injection preparation process is simple, easy control of quality, low cost, convenient for industrial production.